Heart Monitoring Company CardiadSense Raises $3.5 Million

CardiacSense develops a watch-like device that tracks factors like arrhythmia, heart rate, oxygen saturation and blood pressure in users for early detection of stroke or cardiac arrest

Privately-held medical device company CardiacSense Ltd. has raised $3.5 million, the company announced Sunday, bringing its total funding raised to date to $8.5 million.

 

Founded in 2009 and based in coastal Israeli town Caesarea, CardiacSense develops a watch-like device that tracks factors like arrhythmia, heart rate, oxygen saturation and blood pressure in users for early detection of stroke or cardiac arrest. The device uses electrocardiography (ECG) monitoring and photoplethysmography (PPG), an optical technique that detects changes in blood volume, to track the condition of patients and send it directly to their physician in real time.

 

The company is currently in the process of receiving regulatory approval for its device in both the U.S. and Europe, and is gearing up for the second of two clinical trials needed for the process.

 

 

Ilness (illustration). Photo: Shutterstock